Blue Cross and Blue Shield of Texas policy
Denosumab and Biosimilars for Non-Oncologic Indications
Denosumab and Biosimilars for Non-Oncologic Indications is a public Blue Cross and Blue Shield of Texas policy (policy RX501.140). It lists 14 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- RX501.140
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Open official prior authorization lists to check the member’s product.
| Code | Other Blue Cross and Blue Shield of Texas policies |
|---|---|
| C9399 | Policies naming C9399 |
| J0897 | Policies naming J0897 |
| J3490 | Policies naming J3490 |
| J3590 | Policies naming J3590 |
| J9999 | Policies naming J9999 |
| Q5136 | Policies naming Q5136 |
| Q5157 | Policies naming Q5157 |
| Q5158 | Policies naming Q5158 |
| Q5159 | Policies naming Q5159 |
| Q5161 | Policies naming Q5161 |
| Q5162 | Policies naming Q5162 |
| Q5166 | Policies naming Q5166 |
| Q5167 | Policies naming Q5167 |
| Q5171 | Policies naming Q5171 |
All Blue Cross and Blue Shield of Texas policies · Blue Cross and Blue Shield of Texas prior authorization CPT list